BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 5656067)

  • 1. Anomalous differential effects of 4-hydroxypyrazolo (3,4-d)-pyrimidine on electron transfer from xanthine oxidase to molecular oxygen and to acceptor dyes.
    Johns DG
    Biochem Biophys Res Commun; 1968 Apr; 31(2):197-202. PubMed ID: 5656067
    [No Abstract]   [Full Text] [Related]  

  • 2. Oxidation of 4-hydroxypyrazolo (3,4-d) pyrimidine by xanthine oxidase, the route of electron transfer from substrate to acceptor dyes.
    Spector T; Johns DG
    Biochem Biophys Res Commun; 1968 Sep; 32(6):1039-44. PubMed ID: 5750222
    [No Abstract]   [Full Text] [Related]  

  • 3. 4-Hydroxypyrazolo (3,4-d) pyrimidine as a substrate for xanthine oxidase: loss of conventional substrate activity with catalytic cycling of the enzyme.
    Spector T; Johns DG
    Biochem Biophys Res Commun; 1970 Feb; 38(4):583-9. PubMed ID: 5462699
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on the mode of oxidation of pyrazolo(3,4-d)pyrimidine by aldehyde oxidase and xanthine oxidase.
    Johns DG; Spector T; Robins RK
    Biochem Pharmacol; 1969 Oct; 18(10):2371-83. PubMed ID: 5403975
    [No Abstract]   [Full Text] [Related]  

  • 5. 2,6-Dichlorophenolindophenol is a competitive inhibitor for xanthine oxidase and is therefore not usable as an electron acceptor in the fluorometric assay.
    Mest SJ; Kosted PJ; van Kuijk FJ
    Free Radic Biol Med; 1992; 12(3):189-92. PubMed ID: 1563644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The conversion of 4-hydroxypyrazolo[3,4-d]pyrimidine (allopurinol) into 4,6-dihroxypyrazolo[3,4-d]pyrimidine (Oxipurinol) in vivo in the absence of xanthine-oxen oxidoreductase.
    Chalmers RA; Parker R; Simmonds HA; Snedden W; Watts RW
    Biochem J; 1969 May; 112(4):527-32. PubMed ID: 5801674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stoichiometric inhibition of reduced xanthine oxidase by hydroxypyrazolo [3,4-d]pyrimidines.
    Spector T; Johns DG
    J Biol Chem; 1970 Oct; 245(19):5079-85. PubMed ID: 5506275
    [No Abstract]   [Full Text] [Related]  

  • 8. Xanthine oxidase activity in human tissues and its inhibition by allopurinol (4-hydroxypyrazolo[3,4-d] pyrimidine).
    Watts RW; Watts JE; Seegmiller JE
    J Lab Clin Med; 1965 Oct; 66(4):688-97. PubMed ID: 5843095
    [No Abstract]   [Full Text] [Related]  

  • 9. On internal electron transfer in xanthine oxidase.
    Fischer JR; Hurst JK
    Bioinorg Chem; 1978 Aug; 9(2):181-6. PubMed ID: 568006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the specificity toward aldehyde substrates and steady-state kinetics of xanthine oxidase.
    Morpeth FF
    Biochim Biophys Acta; 1983 May; 744(3):328-34. PubMed ID: 6687810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 4-HYDROXYPYRAZOLO (3,4-D) PYRIMIDINE (HPP) IN THE TREATMENT OF GOUT: PRELIMINARY OBSERVATIONS.
    HALL AP; HOLLOWAY VP; SCOTT JT
    Ann Rheum Dis; 1964 Nov; 23(6):439-46. PubMed ID: 14229577
    [No Abstract]   [Full Text] [Related]  

  • 12. Kinetic and e.p.r. studies on the inhibition of xanthine oxidase by alloxanthine (1 H-pyrazolo [3, 4-d] pyrimidine-4,6-diol).
    Williams JW; Bray RC
    Biochem J; 1981 Jun; 195(3):753-60. PubMed ID: 6274312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, screening and docking of fused pyrano[3,2-d]pyrimidine derivatives as xanthine oxidase inhibitor.
    Kaur M; Kaur A; Mankotia S; Singh H; Singh A; Singh JV; Gupta MK; Sharma S; Nepali K; Bedi PMS
    Eur J Med Chem; 2017 May; 131():14-28. PubMed ID: 28286211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of xanthine oxidase by synthetic cytokinin analogues.
    Sheu SY; Lin YC; Chiang HC
    Anticancer Res; 1997; 17(2A):1043-9. PubMed ID: 9137447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behavior of N-methylated allopurinols and related 4-thioxopyrazolo [3,4-d]pyrimidines towards bovine milk xanthine oxidase.
    Bergmann F; Frank A; Govrin H
    Biochim Biophys Acta; 1979 Sep; 570(1):215-20. PubMed ID: 486504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution of reducing equivalents on xanthine oxidase molecules and the rates of the intramolecular electron-transfer reactions.
    Bray RC; Lowe DJ; Barber MJ
    Biochem J; 1974 Jul; 141(1):309-11. PubMed ID: 4375974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. One-electron transfer reactions in biochemical systems. VII. Two types of electron outlets in milk xanthine oxidase.
    Nakamura M; Yamazaki I
    Biochim Biophys Acta; 1973 Dec; 327(2):247-56. PubMed ID: 4360425
    [No Abstract]   [Full Text] [Related]  

  • 18. Substrate inhibition of xanthine oxidase and its influence on superoxide radical production.
    Rubbo H; Radi R; Prodanov E
    Biochim Biophys Acta; 1991 Aug; 1074(3):386-91. PubMed ID: 1653611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-Hydroxyguanidine compound 1-(3,4-dimethoxy- 2-chlorobenzylideneamino)-3-hydroxyguanidine inhibits the xanthine oxidase mediated generation of superoxide radical.
    Dambrova M; Baumane L; Kiuru A; Kalvinsh I; Wikberg JE
    Arch Biochem Biophys; 2000 May; 377(1):101-8. PubMed ID: 10775447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation of bovine milk xanthine oxidase as a dehydrogenase form.
    Nakamura M; Yamazaki I
    J Biochem; 1982 Oct; 92(4):1279-86. PubMed ID: 6959993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.